Larson_ppt.ppt

Views:
 
     
 

Presentation Description

No description available.

Comments

Presentation Transcript

STEPB020399 Evolution of IPR and Pharmaceutical Discovery and Development Eric R. Larson, Ph.D. Pfizer, Inc. Central Research Division Conference on Intellectual Property Rights: How Far Should They Be Extended?

Areas of Leverage/Focus : 

STEPB020399 Areas of Leverage/Focus Discovery and Development Timeframes, Complexity Attrition Regulatory Environment Final therapeutic uses Freedom to Operate

Pharmaceutical Patents - The Changing Landscape : 

STEPB020399 Pharmaceutical Patents - The Changing Landscape Primary uses Processes and intermediates Bulk forms Simple formulations Composition of matter Expansive numbers of uses Methods of treatment Mechanism of action Packaging Delivery profiles Dosing regimen Dosing range Dosing route Combinations Screening Methods Chemistry Methods Biological Target Field of use Primary uses Processes and intermediates Bulk forms Simple formulations Composition of matter 1980’s 1990’s

Innovation will continue, IP sources increase : 

STEPB020399 Innovation will continue, IP sources increase Business Models Portfolio Decision and Analysis, Finance, Marketing Enabling software IT, Biometrics Patient Markers Genomics, Clinical Diagnostics and Measurements Expansive numbers of uses Clinical, Discovery Biology, Drug Safety, Marketing Methods of treatment Clinical, Discovery Biology Mechanism of action Disc. Biology, Molecular Biology Field of use Disc. Biology, Molecular Biology Delivery profiles Clinical, Drug Metabolism, Pharm R&D Dosing regimen Clinical, Drug Metabolism, Pharm R&D Dosing range Clinical, Drug Metabolism, Pharm R&D Dosing route Clinical, Drug Metabolism, Pharm R&D Combinations Clinical, Discovery Biology, Gen. Pharm ,Marketing Packaging Pharm R&D, Marketing Screening methods Discovery Biology, Drug Safety, Drug Metabolism Chemistry Methods Discovery Chemistry, Process R&D Biological Target Genomics, Discovery Biology Primary uses Discovery Biology, Clinical Processes and intermediates Discovery Chemistry, Process R&D Bulk form Discovery Chemistry, Process R&D, Pharm R&D Simple formulations Discovery Chemistry, Pharm R&D Composition of matter Discovery Chemistry, Process R&D Claims for each NCE - Potential Inventors

Costs to ensure freedom to operate : 

STEPB020399 Costs to ensure freedom to operate Capture In-license Work-around Valuation is critical

authorStream Live Help